RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Portage Biotech Stock

Portage Biotech P/E 2024

Portage Biotech P/E

-0.08

Ticker

PRTG

ISIN

VGG7185A1286

WKN

A2P6BP

As of Sep 30, 2024, Portage Biotech's P/E ratio was -0.08, a -99.3% change from the -11.43 P/E ratio recorded in the previous year.

The Portage Biotech P/E history

Portage Biotech Aktienanalyse

What does Portage Biotech do?

Portage Biotech Inc is an international biotechnology company based in Canada. The company was established in 2015 as a holding company and took control of the stock of Biohaven Pharmaceutical Holding Company. Portage Biotech operates in various locations, including Canada, the US, and Europe. The business model of Portage Biotech is based on identifying promising new technologies and creating companies that utilize these technologies. The company employs a strategic investment strategy, acquiring stakes in promising biotechnology companies and working closely with them to bring their products and therapies to market. Another strategy of Portage Biotech is the establishment of innovation centers in different countries. This involves bringing together highly skilled personnel and cutting-edge technologies under one roof to create innovative products and solutions that can be brought to the global market. The company also operates in several business areas, including medical research and development. In this field, Portage Biotech works on developing new therapies, particularly in the field of cancer research. Additionally, the company has a division for medical diagnostics, where innovative testing procedures are developed to contribute to early disease detection. Another important business area for Portage Biotech is the manufacturing of biopharmaceuticals, which are drugs based on biological agents. The company collaborates closely with other biotechnology companies to bring innovative products to the market. Portage Biotech has already successfully implemented a number of promising projects, including the development of therapies for cancer, Alzheimer's, and Parkinson's. The company also has promising biosimilars and biosuperior products in the pipeline that could revolutionize the market. To successfully execute these projects, Portage Biotech has assembled an impressive leadership team. The company has an experienced team of scientists, managers, and professionals who are dedicated to finding the best solutions for the challenges of the biotechnology industry. Overall, Portage Biotech is an innovative company that focuses on the discovery and promotion of promising new technologies. The company has already achieved an impressive track record and has the potential to play a revolutionary role in the field of biotechnology. Portage Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Portage Biotech's P/E Ratio

The Price to Earnings (P/E) Ratio of Portage Biotech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Portage Biotech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Portage Biotech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Portage Biotech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Portage Biotech stock

What is the price-to-earnings ratio of Portage Biotech?

The price-earnings ratio of Portage Biotech is currently -0.08.

How has the price-earnings ratio of Portage Biotech changed compared to last year?

The price-to-earnings ratio of Portage Biotech has increased by -99.3% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Portage Biotech high compared to other companies?

Yes, the price-to-earnings ratio of Portage Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of Portage Biotech affect the company?

An increase in the price-earnings ratio of Portage Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Portage Biotech affect the company?

A decrease in the price-earnings ratio of Portage Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Portage Biotech?

Some factors that influence the price-earnings ratio of Portage Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Portage Biotech pay?

Over the past 12 months, Portage Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Portage Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Portage Biotech?

The current dividend yield of Portage Biotech is .

When does Portage Biotech pay dividends?

Portage Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Portage Biotech?

Portage Biotech paid dividends every year for the past 0 years.

What is the dividend of Portage Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Portage Biotech located?

Portage Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Portage Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Portage Biotech from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Portage Biotech pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Portage Biotech in the year 2023?

In the year 2023, Portage Biotech distributed 0 USD as dividends.

In which currency does Portage Biotech pay out the dividend?

The dividends of Portage Biotech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Portage Biotech

Our stock analysis for Portage Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Portage Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.